A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole. (Q38359488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mary H H Ensom

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Shane Ashley Pawluk

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Craig Allan Roels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

371-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40262-015-0243-9

1 March 2020

exact match

0 references

cites work

Mass drug treatment for lymphatic filariasis and onchocerciasis

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Effect of three anthelmentics on disposition kinetics of florfenicol in goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Effect of the ionophore antibiotic monensin on the ruminal biotransformation of benzimidazole anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

The anthelminthic agent albendazole does not interact with p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

21 January 2018

12 December 2020

Increased systemic availability of albendazole when taken with a fatty meal

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Influence of a Mexican diet on the bioavailability of albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-015-0243-9

Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime

21 January 2018

1 reference

12 December 2020

Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability

1 reference

12 December 2020

Dexamethasone increases plasma levels of albendazole

1 reference

12 December 2020

Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.

1 reference

12 December 2020

Theophylline and antiparasitic drug interactions. A case report and study of the influence of thiabendazole and mebendazole on theophylline pharmacokinetics in adults

1 reference

12 December 2020

Theophylline disposition--effects of cimetidine, mebendazole and albendazole.

1 reference

12 December 2020

In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

1 reference

12 December 2020

The metabolism of benzimidazole anthelmintics

1 reference

12 December 2020

Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

1 reference

12 December 2020

Inhibition and induction of cytochrome P450 and the clinical implications

1 reference

12 December 2020

Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide

1 reference

12 December 2020

Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers.

1 reference

12 December 2020

Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes

1 reference

12 December 2020

Therapy for Neurocysticercosis

1 reference

12 December 2020

Effect of dose increase or cimetidine co-administration on albendazole bioavailability

1 reference

12 December 2020

10.1007/S40262-015-0243-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691367%20AND%20SRC:MED&resulttype=core&format=json